Matos, R., Cordeiro, J. M., Coelho, A., Ferreira, S., et al. (2016). Bladder pain induced by prolonged peripheral alpha 1A adrenoceptor stimulation involves the enhancement of transient receptor potential vanilloid 1 activity and an increase of urothelial adenosine triphosphate release. Acta Physiologica, 218(4), 265 - 275.

Linhares, D. P. S., Garcia, P. V., Silva, C., Barroso, J., et al. (2016). DNA damage in oral epithelial cells of individuals chronically exposed to indoor radon (222Rn) in a hydrothermal area. Environmental Geochemistry and Health.

Canhão, H., Rodrigues, A. M., Santos, M. J., Carmona-Fernandes, D., et al. (2015). TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapy. BioMed Research International, 2015.

Pinto, R., Lopes, T., Silva, J., Silva, C., et al. (2013). Persistent therapeutic effect of repeated injections of onabotulinum toxin A in refractory bladder pain syndrome/interstitial cystitis. Journal of Urology, 189(2), 548 - 553.

Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Exploratory study assessing efficacy and complications of TVT-O, TVT-Secur, and Mini-Arc: Results at 12-month follow-up. European Urology, 59(6), 940 - 944.

Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2011). Intraprostatic botulinum toxin type A administration: Evaluation of the effects on sexual function. BJU International, 107(12), 1950 - 1954.

Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Reply from authors re: Elisabetta costantini and massimo lazzeri. Surgery for stress urinary incontinence: So near and yet so far. Eur Urol 2011;59:945-6. European Urology, 59(6), 947.

Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Single-incision sling system as primary treatment of female stress urinary incontinence: Prospective 12 months data from a single institution. BJU International, 108(10), 1616 - 1621.

Oliveira, R., Silva, C., Dinis, P., & Cruz, F. (2011). Suburethral single incision slings in the treatment of female stress urinary incontinence: What is the evidence for using them in 2010?. Archivos Espanoles de Urologia, 64(4), 339 - 346.

Coelho, A., Dinis, P., Pinto, R., Gorgal, T., et al. (2010). Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder. European Urology, 57(5), 884 - 890.

Kim, S., Silva, C., Zille, A., Lopez, C., et al. (2009). Characterisation of enzymatically oxidised lignosulfonates and their application on lignocellulosic fabrics. Polymer International, 58(8), 863 - 868.

Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2009). Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: Duration of the effect of a single treatment. BMC Urology, 9(1).

Oliveira, R., Silva, A., Pinto, R., Silva, J., et al. (2009). Short-term assessment of a tension-free vaginal tape for treating female stress urinary incontinence. BJU International, 104(2), 225 - 228.

Silva, J., Silva, C., Saraiva, L., Silva, A., et al. (2008). Intraprostatic Botulinum Toxin Type A Injection in Patients Unfit for Surgery Presenting with Refractory Urinary Retention and Benign Prostatic Enlargement. Effect on Prostate Volume and Micturition Resumption. European Urology, 53(1), 153 - 159.

Silva, C., Silva, J., Castro, H., Reis, F., et al. (2007). Bladder sensory desensitization decreases urinary urgency. BMC Urology, 7.

Teixeira, L., Marques, A., Meireles, C. S., Seabra, A. R., et al. (2005). Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites. Immunology, 116(1), 38 - 52.

Lima, M., Costa, M. C., Montiel, R., Ferro, A., et al. (2005). Population genetics of wild-type CAG repeats in the Machado-Joseph Disease gene in Portugal. Human Heredity, 60(3), 156 - 163.

Silva, C., Silva, J., Ribeiro, M. - J., Avelino, A., & Cruz, F. (2005). Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial. European Urology, 48(4), 650 - 655.

Cruz, F., & Silva, C. (2004). Botulinum toxin in the management of lower urinary tract dysfunction: Contemporary update. Current Opinion in Urology, 14(6), 329 - 334.